Everest Medicines Limited 雲 頂 新 耀 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 1952)

Number of shares to

which this form of

proxy relates(Note 1)

FORM OF PROXY FOR THE ANNUAL GENERAL MEETING

TO BE HELD ON TUESDAY, 1 JUNE 2021

I/We(Note 2)

of

being the registered holder(s) of

Share(s) (Note 1) in the issued share capital of

Everest Medicines Limited (the "Company") hereby appoint the Chairman of the meeting (Note 3) or of

as my/our proxy to attend, act and vote for me/us and on my/our behalf as directed below at the annual general meeting (the "AGM") of the Company to be held at Plaza 66, Tower 1, Units 6601-6606, 1266 West Nanjing Road, Shanghai, China on Tuesday, 1 June 2021 at 9 a.m. (and at any adjournment thereof).

Please tick ("") the appropriate boxes to indicate how you wish your vote(s) to be cast (Note 4).

ORDINARY RESOLUTIONS

FOR

AGAINST

1.

To receive and adopt the audited consolidated financial statements of the Company

for the year ended 31 December 2020 and the reports of the Directors and the

auditor independent auditor thereon.

2(a).

To re-elect Mr. Wei Fu as an executive Director.

2(b).

To re-elect Mr. Ian Ying Woo as an executive Director.

2(c).

To re-elect Mr. Xiaofan Zhang as an executive Director.

2(d).

To re-elect Ms. Lan Kang as a non-executive Director.

2(e).

To authorize the board of directors (the "Board") to fix the remuneration of the

Directors.

3.

To re-appoint PricewaterhouseCoopers as the auditor and to authorize the Board to

fix their remuneration.

4.

To grant a general mandate to the directors to repurchase shares of the Company

not exceeding 10% of the total number of issued shares of the Company as at the

date of passing of this resolution.

5.

To grant a general mandate to the directors to issue, allot and deal with additional

shares of the Company not exceeding 20% of the total number of issued shares of

the Company as at the date of passing of this resolution.

6.

To extend the general mandate granted to the directors to issue, allot and deal with

additional shares in the capital of the Company by the aggregate number of the

shares repurchased by the Company.

Date:

, 2021

Signature(s) (Note5)

Notes:

  1. Please insert the number of shares to which this form of proxy relates. If no number is inserted, this form of proxy will be deemed to relate to all the shares of the Company registered in your name(s). If more than one proxy is appointed, the number of shares in respect of which each such proxy so appointed must be specified.
  2. Full name(s) and address(es) to be inserted in BLOCK CAPITALS.
  1. If any proxy other than the Chairman of the meeting is preferred, please strike out the words "the Chairman of the meeting" and insert the name and address of the proxy desired in the space provided. Any shareholder of the Company entitled to attend and vote at the AGM is entitled to appoint any number of proxies (who must be an individual) to attend and vote instead of him. A proxy need not be a shareholder of the Company. Every shareholder present in person or by proxy shall be entitled to one vote for each share held by him.
  2. IMPORTANT: IF YOU WISH TO VOTE FOR A RESOLUTION, PLEASE TICK ("") THE BOX MARKED "FOR". IF YOU WISH TO VOTE AGAINST A RESOLUTION, PLEASE TICK ("") THE BOX MARKED "AGAINST". If no direction is given, your proxy will vote or abstain at his discretion. Your proxy will also be entitled to vote at his discretion on any resolution properly put to the AGM other than those referred to in the notice convening the AGM.
  3. This form of proxy must be signed by you or your attorney duly authorized in writing. In case of a corporation, the same must be either under its common seal or under the hand of an officer or attorney so authorized. ANY ALTERATION MADE TO THIS FORM OF
    PROXY MUST BE INITIALLED BY THE PERSON WHO SIGNS IT.
  4. In case of joint registered holders, any one of such persons may vote at any meeting, either personally or by proxy, in respect of such share as if he were solely entitled thereto; but if more than one of such joint holders be present at any meeting personally or by proxy, that one of the said persons so present being the most or, as the case may be, the more senior shall alone be entitled to vote in respect of the relevant joint holding and, for this purpose, seniority shall be determined by reference to the order in which the names of the joint holders stand on the register in respect of the relevant joint holding.
  5. In order to be valid, this form of proxy, together with the power of attorney or other authority (if any) under which it is signed or a certified copy thereof, must be deposited at the Company's Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wan Chai, Hong Kong not less than 48 hours before the time appointed for the meeting or the adjourned meeting (as the case may be).
  6. Completion and delivery of the form of proxy will not preclude you from attending and voting at the AGM if you so wish.

PERSONAL INFORMATION COLLECTION STATEMENT

Your supply of your and your proxy's (or proxies') name(s) and address(es) is on a voluntary basis for the purpose of processing your request for the appointment of a proxy (or proxies) and your voting instructions for the AGM of the Company (the "Purposes"). We may transfer your and your proxy's (or proxies') name(s) and address(es) to our agent, contractor, or third party service provider who provides administrative, computer and other services to us for use in connection with the Purposes and to such parties who are authorised by law to request the information or are otherwise relevant for the Purposes and need to receive the information. Your and your proxy's (or proxies') name(s) and address(es) will be retained for such period as may be necessary to fulfil the Purposes. Request for access to and/or correction of the relevant personal data can be made in accordance with the provisions of the Personal Data (Privacy) Ordinance and any such request should be in writing by mail to Computershare Hong Kong Investor Services Limited at the above address.

Attachments

  • Original document
  • Permalink

Disclaimer

Everest Medicines Ltd. published this content on 29 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 April 2021 09:10:02 UTC.